We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,314 results
  1. Peroxiredoxins as Markers of Oxidative Stress in IgA Nephropathy, Membranous Nephropathy and Lupus Nephritis

    IgA nephropathy (IgAN), membranous nephropathy (MN), and lupus nephritis (LN) represent important causes of chronic kidney disease. They belong to...

    Natalia Krata, Bartosz Foroncewicz, ... Krzysztof Mucha in Archivum Immunologiae et Therapiae Experimentalis
    Article Open access 16 December 2021
  2. The Association of HMGB1 and RAGE Gene Polymorphisms with IgA Vasculitis

    High-mobility group box 1 (HMGB1) is a pleiotropic cytokine that propagates inflammation by its extracellular action of interacting with the receptor...

    Mateja Batnozic Varga, Martina Held, ... Marija Jelusic in Biochemical Genetics
    Article 30 October 2023
  3. Microorganisms in Pathogenesis and Management of IgA Vasculitis and IgA Nephropathy

    IgA vasculitis is an autoimmune disease characterized by leukocyte infiltration into blood vessels. Infectious agents such as bacteria and viruses...
    Chapter 2022
  4. Lupus nephritis or not? A simple and clinically friendly machine learning pipeline to help diagnosis of lupus nephritis

    Objective

    Diagnosis of lupus nephritis (LN) is a complex process, which usually requires renal biopsy. We aim to establish a machine learning pipeline...

    Da-Cheng Wang, Wang-Dong Xu, ... An-Fang Huang in Inflammation Research
    Article 10 June 2023
  5. IgA vasculitis

    IgA vasculitis (IgAV) is an inflammation of small vessels caused by perivascular deposition of IgA and activation of neutrophils. It may present as...

    Evangéline Pillebout, Cord Sunderkötter in Seminars in Immunopathology
    Article 25 June 2021
  6. Lupus Nephritis: New and Emerging Biologic and Targeted Therapies

    Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE), a polyclonal systemic autoimmunity directed against nuclear and...

    A**ath Kale, Maciej Lech, ... Anil Bhanudas Gaikwad in BioDrugs
    Article 24 April 2023
  7. Angiotensin II Type 1 Receptor Antibodies Are Higher in Lupus Nephritis and Vasculitis than Other Glomerulonephritis Patients

    Angiotensin II type 1 receptor (AT1R) antibodies are considered non-HLA (human leukocyte antigen) antibodies connected with humoral rejection after...

    Maciej Szymczak, Harald Heidecke, ... Mirosław Banasik in Archivum Immunologiae et Therapiae Experimentalis
    Article Open access 24 September 2022
  8. Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation

    Up to 50% of systemic lupus erythematosus (SLE) patients world-wide develop lupus nephritis (LN). In low to middle income countries and in particular...

    Carine Smith, Riette du Toit, Tracey Ollewagen in Inflammopharmacology
    Article Open access 25 August 2023
  9. Clinical Application of Polygenic Risk Score in IgA Nephropathy

    Genome-wide association studies (GWASs) have identified 30 independent genetic variants associated with IgA nephropathy (IgAN). A genetic risk score...

    Linlin Xu, Ting Gan, ... Hong Zhang in Phenomics
    Article 21 March 2024
  10. An Updated Focus on Immune Checkpoint Inhibitors and Tubulointerstitial Nephritis

    One of the most relevant achievements in oncological research is represented by the development of a new category of anticancer drugs, the immune...
    Daniela Picciotto, Carlo Genova, ... Pasquale Esposito in Cancer Treatment: An Interdisciplinary Approach
    Chapter 2023
  11. Spatial proteomics landscape and immune signature analysis of renal sample of lupus nephritis based on laser-captured microsection

    Objective

    We aimed to reveal a spatial proteomic and immune signature of kidney function regions in lupus nephritis (LN).

    Material and methods ...
    Feng** Zheng, Donge Tang, ... Yong Dai in Inflammation Research
    Article Open access 20 July 2023
  12. Protopanaxadiol improves lupus nephritis by regulating the PTX3/MAPK/ERK1/2 pathway

    Lupus nephritis (LN) is a kidney disease that occurs after systemic lupus erythematosus (SLE) affects the kidneys. Pentraxin 3 (PTX3) is highly...

    Zhenyuan Li, Hailin Gan, ... Huaying Fan in Journal of Natural Medicines
    Article 03 March 2024
  13. The influences of α-hemolytic Streptococcus on class switching and complement activation of human tonsillar cells in IgA nephropathy

    While β-hemolytic streptococcus (β-HS) infections are known to predispose patients to acute poststreptococcal glomerulonephritis, there is evidence...

    Muyao Ye, Chang Wang, ... Hong Liu in Immunologic Research
    Article 12 October 2021
  14. Are there animal models of IgA nephropathy?

    Immunoglobulin A (IgA) nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. Up to 40% of IgAN patients develop end-stage...

    Renato C. Monteiro, Yusuke Suzuki in Seminars in Immunopathology
    Article 07 July 2021
  15. New Treatment Options in Lupus Nephritis

    The aim of this study is to report major recent progresses in the treatment of lupus nephritis (LN). Results of controlled randomized trials are...

    Pauline M. Montigny, Frédéric A. Houssiau in Archivum Immunologiae et Therapiae Experimentalis
    Article 17 March 2022
  16. Complement activation in IgA nephropathy

    IgA nephropathy pathogenesis is incompletely understood, and this limits the development of disease-specific biomarkers and effective therapies....

    Nicholas R. Medjeral-Thomas, H. Terence Cook, Matthew C. Pickering in Seminars in Immunopathology
    Article Open access 11 August 2021
  17. Omics are Getting Us Closer to Understanding IgA Nephropathy

    During the last decade, thanks to omics technologies, new light has been shed on the pathogenesis of many diseases. Genomics, epigenomics,...

    Krzysztof Mucha, Michał Pac, Leszek Pączek in Archivum Immunologiae et Therapiae Experimentalis
    Article Open access 15 April 2023
  18. Clinical relevance of glomerular IgM deposition in patients with lupus nephritis

    Background

    The aim of the study was to investigate the clinical relevance of IgM deposition in patients with lupus nephritis (LN) in a large cohort.

    ...
    Fengmei Wang, Jirong Yu, ... **aowei Yang in BMC Immunology
    Article Open access 07 December 2021
  19. IgA glycosylation and immune complex formation in IgAN

    IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. This disease, discovered in 1968, is characterized by IgA-IgG...

    Hitoshi Suzuki, Jan Novak in Seminars in Immunopathology
    Article 27 September 2021
  20. Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysis

    Background

    IgA nephropathy (IgAN) has become the leading cause of end-stage renal disease in young adults. Nevertheless, the current diagnosis...

    **aohui Li, Mengru Zeng, ... Li **ao in BMC Medical Genomics
    Article Open access 28 March 2023
Did you find what you were looking for? Share feedback.